West, BD, YPSOMED, Roche have prefilled pumps.
There is lots of language...and the date of first publication to suggest it has nothing to do with UNS.
Its not to say that since this patent filing a number of device companies have come to the party with devices so less of a need for Abbott-Abbvie to do their own device like Roche etc. Rather they now have the simpler option is to buy the tech
Funny...up until yesterday Abbvie were one of the people i thought the UNS 1ml pump could do a deal for Humira especially since it was being trialled with Halozyme.
But Abbvie just pulled out if Humira-Halozyme development so that is a new variable. It can still be used with a pump and perhaps added no extra benefit but too early to really say.
- Forums
- ASX - By Stock
- UNS
- Wearable Injectors
Wearable Injectors, page-10
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online